Codrituzumab Uses, Dosage, Side Effects and more
Codrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma).
| Trade Name | Codrituzumab |
| Generic | Codrituzumab |
| Codrituzumab Other Names | Codrituzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
